Icu Medical (ICUI) Liabilities and Shareholders Equity (2009 - 2026)
Icu Medical's (ICUI) quarterly Liabilities and Shareholders Equity came in at $4.0 billion in Q2 2026, down 3.31% on a YoY basis from $4.1 billion in Q2 2025, and down 1.06% quarter-over-quarter from $4.0 billion in Q1 2026.
Powered by 
Analysis
Icu Medical (ICUI) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Icu Medical (ICUI) has reported Liabilities and Shareholders Equity for 18 consecutive years, with $4.0 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Liabilities and Shareholders Equity fell 3.31% year-over-year to $4.0 billion; the trailing twelve-month figure through Jun 2026 stood at $16.1 billion (down 3.94% YoY), and the FY2025 full-year result was $4.1 billion, down 3.65% from the prior year.
- Liabilities and Shareholders Equity declined to $4.0 billion in Q2 2026 per ICUI's latest filing, from $4.0 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $4.7 billion in Q1 2022 and bottomed at $4.0 billion in Q2 2026.
- Historically, Liabilities and Shareholders Equity has averaged $4.3 billion across 5 years, with a median of $4.3 billion in 2024.
- The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity surged 168.9% in 2022, then dropped 5.82% in 2023.
- Over 5 years, Liabilities and Shareholders Equity stood at $4.5 billion in 2022, then retreated by 3.04% to $4.4 billion in 2023, then retreated by 3.99% to $4.2 billion in 2024, then decreased by 3.65% to $4.1 billion in 2025, then dropped by 1.96% to $4.0 billion in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $4.0 billion, $4.0 billion, and $4.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | 93.31 Bn |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | 47.93 Bn |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | 13.87 Bn |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | 6.46 Bn |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | 8.97 Bn |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | 31.10 Bn |
| 10 | Icu Medical | 3.82 Bn | 3.52 Bn | 235.05 Mn | 3.97 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.97 Bn |
| Mar 31, 2026 | 4.01 Bn |
| Dec 31, 2025 | 4.05 Bn |
| Sep 30, 2025 | 4.10 Bn |
| Jun 30, 2025 | 4.11 Bn |
| Mar 31, 2025 | 4.18 Bn |
| Dec 31, 2024 | 4.20 Bn |
| Sep 30, 2024 | 4.31 Bn |
| Jun 30, 2024 | 4.29 Bn |
| Mar 31, 2024 | 4.29 Bn |
| Dec 31, 2023 | 4.38 Bn |
| Sep 30, 2023 | 4.38 Bn |
| Jun 30, 2023 | 4.46 Bn |
| Mar 31, 2023 | 4.47 Bn |
| Dec 31, 2022 | 4.52 Bn |
| Sep 30, 2022 | 4.45 Bn |
| Jun 30, 2022 | 4.59 Bn |
| Mar 31, 2022 | 4.75 Bn |
| Dec 31, 2021 | 1.88 Bn |
| Sep 30, 2021 | 1.84 Bn |